EUVIMEDEUVIMED entdecken
Crossref

Second primary malignancy for early‐stage head and neck squamous cell carcinoma by SEER 17 registries

Hanqing Lin iD, Xiaobo Wu, Guangnan Yao, Zhihong Chen, Yuanteng Xu, Gongbiao Lin, Chang Lin

Oral Diseases · 2025

DOI: 10.1111/odi.15083 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Hanqing Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology, Fujian Institute of Otorhinolaryngology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Neoplasms, Second Primary, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Startup Fund for Talents of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Investigating treatment modalities' association with second primary malignancy risk in early‐stage head and neck squamous cell carcinoma (HNSCC).

Methods

Data of 5‐year survivors of early‐stage (stages I–II, seventh TNM staging manual) HNSCC from 2000 to 2020 were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Standardized incidence ratio and excess absolute risk were used to assess second primary malignancy (SPM) development externally. Relative risk was estimated to compare SPM risk within groups. Fine‐Gray's model estimated cumulative incidence of second primary malignancy.

Results

Overall, 8957 5‐year survivors with early‐stage HNSCC were enrolled. Patients receiving definitive radiotherapy had poorer survival than surgery patients. Surgery correlated with lower risk of second primary malignancy (RR = 0.89, 95% CI 0.80–0.99), especially for oropharyngeal squamous cell carcinoma (RR = 0.56, 95% CI 0.39–0.82). Differences in the risk of second primary malignancy among subgroups based on clinical characteristics were not significant. Treatment modalities did not significantly affect risk of second primary malignancy within each subgroup.

Conclusions

Surgery led to better survival and lower risk of second primary malignancy compared to definitive radiotherapy in 5‐year survivors. Incidence and sites of second primary malignancy varied by primary sites, emphasizing targeted long‐term surveillance's importance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neoplasms, Second PrimarySquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansSEER ProgramMaleFemaleMiddle AgedAgedIncidenceNeoplasm StagingUnited StatesAdultRegistries

Stichwörter der Autor:innen

SEERdefinitive radiotherapyearly stagehead and neck squamous cell carcinomasecond primary malignancysurgery

Autor:innen und Institutionen

  • Department of Otolaryngology, Fujian Institute of Otorhinolaryngology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Fujian Branch Center of National Clinical Research Center for Otorhinolaryngologic Diseases, Fujian Clinical Research Center for Difficult Diseases of Otorhinolaryngology, The First Affiliated Hospital of Fujian Medical…
  • National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China.

ORCID-Profile: Hanqing Lin

Förderung

  • Startup Fund for Talents of Fujian Province

Zitieren

APA

Lin, H., Wu, X., Yao, G., Chen, Z., Xu, Y., Lin, G., & Lin, C. (2025). Second primary malignancy for early‐stage head and neck squamous cell carcinoma by SEER 17 registries. Oral Diseases. https://doi.org/10.1111/odi.15083

Vancouver

Lin H, Wu X, Yao G, Chen Z, Xu Y, Lin G, et al. Second primary malignancy for early‐stage head and neck squamous cell carcinoma by SEER 17 registries. Oral Diseases. 2025. doi:10.1111/odi.15083

BibTeX
@article{Lin2025,
  author = {Lin, Hanqing and Wu, Xiaobo and Yao, Guangnan and Chen, Zhihong and Xu, Yuanteng and Lin, Gongbiao and Lin, Chang},
  title = {Second primary malignancy for early‐stage head and neck squamous cell carcinoma by SEER 17 registries},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.15083}
}
Kostenlos starten →